Topic
Addiction medicine
About: Addiction medicine is a research topic. Over the lifetime, 1070 publications have been published within this topic receiving 23685 citations.
Papers published on a yearly basis
Papers
More filters
6 citations
Waterford Institute of Technology1, University of Pretoria2, University of Health Sciences Antigua3, University of the Witwatersrand4, Ain Shams University5, Post Graduate Institute of Medical Education and Research6, Mahidol University7, Tribhuvan University8, University of Auckland9, All India Institute of Medical Sciences10, University of Malaya11, University of Indonesia12, College of Health Sciences, Bahrain13, Sidi Mohamed Ben Abdellah University14, University of Cape Town15, Radboud University Nijmegen16
6 citations
TL;DR: In Paul Cotton's article in the Medical News & Perspectives section of JAMA 1 describing basic benefits in various health insurance plans, the author erroneously states that the American Medical Association's plan does not cover detoxification.
Abstract: To the Editor —In Paul Cotton's article in the Medical News & Perspectives section of JAMA 1 describing basic benefits in various health insurance plans, the author erroneously states that the American Medical Association's plan does not cover detoxification Detoxification originally was excluded in Health Access America's basic benefits package, but the Medical Society of the State of New York and the American Society of Addiction Medicine argued at the 1991 Interim Meeting that if the exclusion were to stand, it would have many negative repercussions, including setting exclusion of detoxification as the standard for health insurers; sending a message that detoxification is not part of the mainstream of acute medical care; deterring hospitals from establishing detoxification services or from maintaining present services; admitting alcoholics to hospitals under alternative diagnoses and lessening opportunities for adequate follow-up care; and taking a giant step backward in the effort to aid persons suffering
6 citations
TL;DR: Further studies are needed on the neurologic, cognitive, and behavioral sequelae of opioid overdose in order to develop an effective long-term treatment strategy to manage the healthcare needs of this population.
Abstract: To review the literature regarding neurologic, cognitive, and behavioral disorders resulting from non-fatal opioid overdose. Although there is extensive literature regarding hypoxic-ischemic brain injury resulting from cardiac arrest, studies specifically examining opioid-induced brain injury are limited, derived mainly from patient case reports or animal models. Medical management of this population requires careful consideration of acute and long-term complications, as well as careful treatment planning in coordination with neurology, neuropsychology, psychiatry, and addiction medicine. In addition to interventions to prevent fatal opioid overdose, further studies are needed on the neurologic, cognitive, and behavioral sequelae of opioid overdose in order to develop an effective long-term treatment strategy to manage the healthcare needs of this population.
6 citations
TL;DR: Examination of physicians’ perceptions of the provision of ancillary services for opioid dependent patients receiving buprenorphine treatment found that counseling availability differed significantly by provider specialization for any, individual, group, family or couples, and self-help groups.
Abstract: OBJECTIVE We set out to examine physicians' perceptions of the provision of ancillary services for opioid dependent patients receiving buprenorphine. METHODS An e-mail invitation describing the study was sent out by the American Society of Addiction Medicine to its membership (approximately 3700 physicians) and other entities (for a total of approximately 7000 e-mail addresses). E-mail recipients were invited to participate in a research study funded by the National Institutes on Drug Abuse involving completion of an online survey; 346 physicians completed the survey. RESULTS The majority of the 346 respondents were internal or family medicine (37%), or addiction medicine providers (30%), who were practicing in urban (57%) or suburban settings (27%). Most respondents reported either offering (66%) or referring patients for ancillary counseling (31%). Interventions that were most frequently offered or referrals provided were individual counseling (51%) and self-help groups (63%), respectively. Counseling availability differed significantly by provider specialization for any, individual, group, family or couples, and self-help groups. CONCLUSIONS Generally, respondents reported compliance with ancillary counseling requirements for buprenorphine treatment of opioid use disorder. In addition to examining the efficacy of a variety of ancillary counseling services for patients receiving opioid agonist treatment, further research should examine physicians' attitudes toward the role of such counseling in buprenorphine treatment. Although the study sample was relatively large, the generalizability of the findings is unclear, suggesting that further investigation of the availability of ancillary counseling in buprenorphine treatment among a larger nationally representative sample of providers may be warranted.
6 citations